Journal
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Volume 32, Issue 1, Pages -Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.urolonc.2012.11.013
Keywords
miR-154; Prostate cancer; CCND2
Categories
Funding
- Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University
- Provincial Initiative Program for Excellency Disciplines of Jiangsu Province
- National Natural Science Foundation of China [81171963, 81102089]
- Natural Science Foundation of Jiangsu Province [BK2008473, BK2011773]
Ask authors/readers for more resources
Background: Research has shown reduced expression levels of miR-154 in prostate cancer (CaP). However, the function and molecular mechanisms of miR-154 in this cancer type remains unknown. Objective: The aims of this study were to examine the functional significance of miR-154 in CaP cells and to identify the novel molecular targets regulated by miR-154. Materials and methods: miR-154 expression significantly decreased in primary CaP samples compared with nonmalignant samples measured by quantitative reverse transcription polymerase chain reaction. Restoration of miR-154 lowered the potential of CaP cell lines to grow and proliferate in vitro evaluated by CCK-8 assay, colony formation assay, and flow cytometry. miR-154 down-regulated the expression of CCND2 by binding to its 3'-untranslated region by luciferase reporter assay. Conclusions: miR-154 plays a prominent role in CaP proliferation by suppressing CCND2, and it may provide a new approach to the treatment of CaP. (C) 2014 Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available